+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Endometrial Cancer Treatment Market Report 2025 - Product Thumbnail Image

Endometrial Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
From
Smart Life Sciences Manufacturing Market Report 2025 - Product Thumbnail Image

Smart Life Sciences Manufacturing Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Biotechnology Services Market Report 2025 - Product Thumbnail Image

Biotechnology Services Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Biotech Ingredient Market Report 2025 - Product Thumbnail Image

Biotech Ingredient Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
Ophthalmic Drugs Market Report 2025-2035 - Product Thumbnail Image

Ophthalmic Drugs Market Report 2025-2035

  • Report
  • December 2024
  • 340 Pages
  • Global
From
From
Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2024 - Product Thumbnail Image

Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Loading Indicator